Reference health

Differences in cardiovascular safety with non‐steroidal anti‐inflammatory drug therapy—A nationwide study in patients with osteoarthritis

https://doi.org/10.1111/bcpt.13182
CiteStamped reference-health badge
32/32 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 32 checked references that resolve
resolves10.1371/journal.pmed.1001388
Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
resolves10.1056/NEJM200011233432103
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
resolves10.1056/NEJMoa050405
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
resolves10.1016/S0140-6736(06)69666-9
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
resolves10.1093/bmb/lds038
Epidemiology and burden of osteoarthritis
resolves10.1093/rheumatology/kei049
The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition
resolves10.1016/j.joca.2014.01.003
OARSI guidelines for the non-surgical management of knee osteoarthritis
resolves10.1038/srep39672
Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies
resolves10.1016/j.tips.2017.05.008
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
resolves10.1136/bmj.j1909
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
resolves10.1056/NEJMoa1611593
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
resolves10.1002/cpt.696
Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post‐PRECISION: What We Thought We Knew Then and What We Think We Know Now
resolves10.1161/CIRCULATIONAHA.117.027288
Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs
resolves10.1111/bcpt.13059
Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies
resolves10.7326/M13-1581
Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy
resolves10.1371/journal.pmed.1001098
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
resolves10.1016/S0735-1097(01)01109-3
Development and validation of the ontario acute myocardial infarction mortality prediction rules
resolves10.1161/CIRCULATIONAHA.107.720847
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
resolves10.2147/CLEP.S91125
The Danish National Patient Registry: a review of content, data quality, and research potential
resolves10.1016/j.jacc.2014.03.039
Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease
resolves10.1002/pds.1200
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
resolves10.1172/JCI27291
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
resolves10.1161/01.CIR.0000124715.27937.78
Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects
resolves10.1016/j.clinthera.2011.10.019
Patterns of Therapy Switching, Augmentation, and Discontinuation After Initiation of Treatment With Select Medications in Patients With Osteoarthritis
resolves10.1002/pds.653
Drug switching patterns among patients taking non‐steroidal anti‐inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom
resolves10.1136/gut.52.9.1265
Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs
resolves10.1136/bmj.332.7553.1302
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
resolves10.1016/j.jacc.2018.02.036
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
resolves10.1016/j.ahj.2008.12.014
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
resolves10.1016/j.prostaglandins.2006.05.019
Pharmacodynamic of cyclooxygenase inhibitors in humans
resolves10.1016/S0140-6736(13)60900-9
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
The 3 references without a DOI — listed, not checked
no DOI — not checkedRytgaardH.C. GerdsT.A.From %x_recepter to Rcpp: a mathematical formulation of the algorithm a new R‐user interface and an efficient implementation [Internet]. Available from:https://github.com/tagteam/heaven/blob/master/worg/medicin-macro.pdf.
no DOI — not checkedChouR McDonaghMS NakamotoE GriffinJ.Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review [Internet].Rockville MD:Agency for Healthcare Research and Quality (US);2011[cited 2018 Dec 5]. Available from:http://www.ncbi.nlm.nih.gov/books/NBK65646/
no DOI — not checkedRandomized trial of switching from prescribed non‐selective non‐steroidal anti‐inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/bcpt.13182"><img src="https://citestamp.com/citestamped/10.1111/bcpt.13182/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/bcpt.13182/badge.svg)](https://citestamp.com/citestamped/10.1111/bcpt.13182)